MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-29-2025
NeoGenomics Cash and Cash Equivalents 2011-2026 | NEO
Annual Cash and Cash Equivalents NeoGenomics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 367 M | 342 M | 263 M | 317 M | 229 M | 173 M | 9.81 M | 12.8 M | 12.5 M | 23.4 M | 33.7 M | 4.83 M | 1.87 M | 2.63 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 367 M | 1.87 M | 128 M |
Quarterly Cash and Cash Equivalents NeoGenomics
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 155 M | 346 M | 367 M | 362 M | 355 M | 332 M | 342 M | 306 M | 289 M | 276 M | 263 M | 266 M | 284 M | 306 M | 317 M | 341 M | 369 M | 612 M | 251 M | 229 M | 229 M | 229 M | 173 M | 173 M | 173 M | 173 M | 9.81 M | 9.81 M | 9.81 M | 9.81 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 4.83 M | 4.83 M | 4.83 M | 4.83 M | 1.87 M | 1.87 M | 1.87 M | 1.87 M | 2.63 M | 2.63 M | 2.63 M | 2.63 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 612 M | 1.87 M | 137 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
1.24 M | $ 3.04 | -1.94 % | $ 98.7 K |  USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
69.3 M | $ 23.73 | -1.33 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 33.99 | 0.65 % | $ 366 M |  China |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
9.17 M | $ 1.45 | -1.36 % | $ 1.84 M | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M | Israel |
 |
Castle Biosciences
CSTL
|
120 M | $ 38.58 | -1.48 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
14.9 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
2.08 B | $ 220.11 | 0.3 % | $ 161 B | USA |
 |
Exact Sciences Corporation
EXAS
|
601 M | $ 102.53 | 0.22 % | $ 19 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 26.1 | -0.55 % | $ 789 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
526 M | $ 111.68 | 1.09 % | $ 13.7 B | USA |
 |
DexCom
DXCM
|
566 M | $ 73.38 | -0.84 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
82.2 M | $ 20.61 | -0.91 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
22.5 M | $ 111.47 | -0.58 % | $ 4.4 B | USA |
 |
DarioHealth Corp.
DRIO
|
36.8 M | $ 11.0 | 6.8 % | $ 312 M | Israel |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
913 M | $ 66.0 | -1.02 % | $ 4.57 B | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 147.19 | -1.67 % | $ 23.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
1.7 B | $ 230.76 | -2.0 % | $ 41.8 B | USA |
 |
Charles River Laboratories International
CRL
|
195 M | $ 210.0 | -0.83 % | $ 10.8 B | USA |
 |
Medpace Holdings
MEDP
|
669 M | $ 584.19 | -1.5 % | $ 18.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
549 M | $ 184.39 | 1.14 % | $ 20.5 B | USA |
|
Biodesix
BDSX
|
26.2 M | $ 9.1 | -5.8 % | $ 1.18 B | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
1.5 M | $ 24.39 | 0.54 % | $ 31.7 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.52 B | $ 269.89 | 0.03 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
59.4 M | $ 1 392.56 | -0.02 % | $ 29.6 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 177.62 | -4.45 % | $ 14.7 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
288 M | $ 676.0 | -0.1 % | $ 55.7 B | USA |
 |
Personalis
PSNL
|
91.4 M | $ 9.44 | -5.37 % | $ 559 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.4 B | $ 28.83 | -1.45 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
1.48 B | $ 133.08 | -0.12 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.35 | -1.67 % | $ 5.4 M | USA |